Transplant and Treatment Options for Patients with Hepatocellular Carcinoma
April 19, 2011•15 min
Host: Aaron Carroll, MD Guest: Mary Maluccio, MD, MPH While the incidence of many types of cancer in the United States has decreased in recent years, the incidence of hepatocellular carcinoma, secondary to either hepatitis B or cirrhosis, has been on the rise. And, of the treatment options including resection, ablation and transplantation, what tumor characteristics determine treatment and which patients might benefit most from liver transplant? Dr. Mary Maluccio, director of the liver oncology program at Indiana University Health, discusses the advantages of transplant, the length of time that patients generally wait to receive a donor liver and the criteria for donor organs. Hosted by Dr. Aaron Carroll.